Presentation is loading. Please wait.

Presentation is loading. Please wait.

Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non–small cell lung cancer  Dominique H. Grunenwald, MDa, Fabrice André, MDb,

Published byMartina Waters Modified over 5 years ago

Similar presentations

Presentation on theme: "Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non–small cell lung cancer  Dominique H. Grunenwald, MDa, Fabrice André, MDb,"— Presentation transcript:

1 Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non–small cell lung cancer 
Dominique H. Grunenwald, MDa, Fabrice André, MDb, Cécile Le Péchoux, MDc, Philippe Girard, MDa, Christian Lamer, MDd, Agnès Laplanche, MDe, Michèle Tarayre, e, Rodrigo Arriagada, MDc, Thierry Le Chevalier, MDb  The Journal of Thoracic and Cardiovascular Surgery  Volume 122, Issue 4, Pages (October 2001) DOI: /mtc Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

2 Fig. 1 Study design. 5 FU, 5-Fluorouracil; CDDP, cis-diaminedichloroplatinum; D, day. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

3 Fig. 2 Survival of the overall population.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

4 Fig. 3 Survival according to postinduction lymph node status and resection. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

5 Fig. 4 Survival of partial responders.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2001 American Association for Thoracic Surgery Terms and Conditions

Download ppt "Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non–small cell lung cancer  Dominique H. Grunenwald, MDa, Fabrice André, MDb,"

Similar presentations

The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications Jih-Shiuan Wang, MD, Dominique.

The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications Jih-Shiuan Wang, MD, Dominique.
Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,
Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: Activation of the mitochondria-dependent death-signaling.

Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: Activation of the mitochondria-dependent death-signaling.
Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Synchronous multiple primary lung cancer: An increasing clinical occurrence requiring multidisciplinary management  Delphine Trousse, MD, Fabrice Barlesi,

Synchronous multiple primary lung cancer: An increasing clinical occurrence requiring multidisciplinary management  Delphine Trousse, MD, Fabrice Barlesi,
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Uz Stammberger, MDa, Jürg Hamacher, MDb, Sven Hillinger, MDc, Ralph A

Uz Stammberger, MDa, Jürg Hamacher, MDb, Sven Hillinger, MDc, Ralph A
Radical en bloc resection for lung cancer invading the spine

Radical en bloc resection for lung cancer invading the spine
Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer  Masahiko Higashiyama, MDa, Ken Kodama,

Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer  Masahiko Higashiyama, MDa, Ken Kodama,
The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer  Kyong-Ah Yoon,

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer  Kyong-Ah Yoon,
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.

Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.
Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy  Morihito Okada, MD, Hiroyuki Yamagishi,

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy  Morihito Okada, MD, Hiroyuki Yamagishi,
Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer  Walter Weder, MD, Stéphane Collaud, MD,

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer  Walter Weder, MD, Stéphane Collaud, MD,
Nael Martini, MDa, Manjit S. Bains, MDa, Michael E

Nael Martini, MDa, Manjit S. Bains, MDa, Michael E
Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma  Nader Abedallaa, MD, Lise Tremblay, MD, Charlotte.

Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma  Nader Abedallaa, MD, Lise Tremblay, MD, Charlotte.
Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD 

Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD 
Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Similar presentations

Ads by Google